European Parliament Wants To Write The Rules For Digital Trade 12/12/2017 by Monika Ermert for Intellectual Property Watch Leave a Comment The European Parliament today adopted a report that lays out a European digital trade strategy. Adopted by a margin of 510 to 95 in Strasbourg, the report obliges the Commission to make digital trade an essential part in the European trade policy.
Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 by Intellectual Property Watch Leave a Comment The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications.
Analysis: As Biosimilar Of Key Cancer Drug Spreads, Where Is The Price Reduction? 11/12/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment The first biosimilar of the blockbuster breast cancer drug trastuzumab is being prepared for launch in United States, following a decision by the Food and Drug Administration (FDA) to approve it earlier this month. The product, Ogivri, has been created by a joint venture between US Mylan and Indian company Biocon.
EPO Study Shows Rise In Patents On Next Generation Technologies 11/12/2017 by Intellectual Property Watch Leave a Comment The European Patent Office (EPO) today announced a study that showed “European patent applications related to smart connected objects are rising rapidly, achieving a growth rate of 54% in the last three years.”
Special Feature: 5G And Standard Essential Patents In The US 08/12/2017 by William New, Intellectual Property Watch Leave a Comment NEW YORK — A panel at the recent IP Dealmakers Forum including a US Federal Trade Commission official, a former US judge on a key patent case, and a telecommunications industry licensing expert walked through issues and prospects for the coming of the 5G next generation wireless technology. Views differed on points but panellists agreed that changes are needed to the system for standard-essential patents, including a bigger role for standard-setting organisations. Below is an in-depth account of the discussion. The discussion also included the latest state-of-play at the FTC, which currently has its lowest number of commissioners ever.
Copyright Skirmishes From The European Snippet War 08/12/2017 by Monika Ermert for Intellectual Property Watch Leave a Comment A new European Union ancillary copyright provision for news publishers will help them against news aggregators and platform providers, promised proponents and two panellists favouring the addition of the EU Copyright Reform at a workshop of the Justice Committee (JURI) of the European Parliament in Brussels today (7 December). But it’s a promise that cannot be kept according to a study commissioned by the Parliament and also presented during a feisty discussion at the workshop.
EU Parliament Justice Committee Ponders Regulation Of Copyright And Liability In 3D Printing 07/12/2017 by Intellectual Property Watch Leave a Comment Should the European Parliament consider regulation on 3D printing with regard to intellectual property protection and civil liability? Members of the Justice Committee (JURI) today at their session in Brussels were divided with representatives from the Green Party group as well as the conservatives and liberals cautioning against erecting barriers to the technology.
International Labour Organization Orders Reinstatement Of EPO Appeals Judge 06/12/2017 by Dugie Standeford for Intellectual Property Watch 2 Comments In an extraordinary 6 December session, the UN International Labour Organization Administrative Tribunal (ILOAT) handed down five decisions involving the European Patent Office (EPO), one of which reinstated a suspended Board of Appeals judge. The cases are just “the tip of the iceberg,” said the Staff Union of the EPO (SUEPO).
New UNCTAD, GIZ Toolbox: How To Achieve Policy Coherence For Local Production And Access To Medicines 05/12/2017 by Guest contributor for Intellectual Property Watch Leave a Comment What do investment, trade, intellectual property, health financing, R&D, industrial and medicines regulation policy have in common? They are all important building blocks for the successful promotion of local pharmaceutical manufacturing. As more and more countries are looking into building their own pharmaceutical production capacities, they need to ensure strong policy coherence to be successful.
Must All Foreigners Online Comply With US Copyright Law? (Part 2 of 2) 05/12/2017 by Steven Seidenberg for Intellectual Property Watch Leave a Comment A case now before the DC Circuit Court of Appeals, Spanski Enterprises v. Telewizja Polska, creates a legal dilemma. The court needs to find Telewizja liable for copyright infringement, or else the court will create a roadmap for pirates, enabling them to stream copyrighted works into the US with impunity. But if the court finds Telewizja committed infringement simply because the Polish company put online works that could be accessed in the US, the court will apply US copyright law in an extraterritorial manner that will create problems around the globe.